Targeting LncRNA ADAMTS9-AS1 is a Promising Therapeutic Strategy to Inhibit the Progression of Bladder Cancer

Zhu Yu, Gongxiang Tan, Chunyan Yu, Yamei Chen, Huijie Zheng, Wenfang Xu, Mingzhu Yu

PDF(10208 KB)
For Authors|For Editors|For Reviewers
PDF(10208 KB)
Discovery Medicine ›› 2024, Vol. 36 ›› Issue (191) : 2454-2464. DOI: 10.24976/Discov.Med.202436191.226
Article

Targeting LncRNA ADAMTS9-AS1 is a Promising Therapeutic Strategy to Inhibit the Progression of Bladder Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 36(191): 2454-2464 https://doi.org/10.24976/Discov.Med.202436191.226

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(10208 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2024.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.

    • /

    〈 〉